S 1662
117th Congress
Senate
Health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Food and Drug Administration (FDA)
Medical research
National Institutes of Health (NIH)
Research administration and funding
Social work, volunteer service, charitable organizations
Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act
Everywhere this bill has been
19 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 15, 2022
Became Public Law No: 117-101.
Mar 15, 2022
Signed by President.
Mar 3, 2022
Presented to President.
Feb 28, 2022
Motion to reconsider laid on the table Agreed to without objection.
Feb 28, 2022
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1159)
Feb 28, 2022
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1159)
Feb 28, 2022
DEBATE - The House proceeded with forty minutes of debate on S. 1662.
Feb 28, 2022
Considered under suspension of the rules. (consideration: CR H1159-1160)
Feb 28, 2022
Mr. Pallone moved to suspend the rules and pass the bill.
Jun 28, 2021
Held at the desk.
Jun 28, 2021
Received in the House.
Jun 28, 2021
Message on Senate action sent to the House.
Jun 24, 2021
Passed Senate without amendment by Voice Vote. (consideration: CR S4793; text: CR S4793)
Jun 24, 2021
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S4793; text: CR S4793)
Jun 14, 2021
Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.
Jun 14, 2021
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray without amendment. Without written report.
May 25, 2021
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
May 17, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 17, 2021
Introduced in Senate
Plain-English summary
Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act
This bill increases the amount of funds each fiscal year that the Food and Drug Administration (FDA) must transfer to the Reagan-Udall Foundation for the FDA and that the National Institutes of Health (NIH) must transfer to the Foundation for the NIH.
Specifically, it requires each agency to increase the amount transferred to its respective foundation (1) from a minimum of $500,000 to a minimum of $1,250,000, and (2) from a maximum of $1,250,000 to a maximum of $5,000,000.
What's happening now
Became Public Law No: 117-101.
Committees of jurisdiction
1
Cosponsors
1